Drug
Denufosol tetrasodium clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
14 studies that test it; most in 2005 (4)
| Year | Studies |
|---|---|
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 14 · Other 0
Studies
Open first, then newest update. How each study uses denufosol tetrasodium is read from its arms, and is right about nine times in ten.
Testing it · 14
- Study to Treat Uveitis Associated Macular EdemaTerminatedPhase 2Merck Sharp & Dohme LLCNCT00114062Written as denufosol tetrasodium (INS37217) Intravitreal Injection
- A Study in Subjects With Perennial Allergic RhinitisCompletedPhase 2Merck Sharp & Dohme LLCNCT00210015Written as INS37217 Nasal Spray
- Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung DiseaseCompletedPhase 3Merck Sharp & Dohme LLCNCT00357279Written as denufosol tetrasodium (INS37217) Inhalation Solution
- Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung DiseaseCompletedPhase 3Merck Sharp & Dohme LLCNCT00625612Written as Denufosol Tetrasodium (INS37217) Inhalation Solution
- Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung DiseaseCompletedPhase 2Merck Sharp & Dohme LLCNCT00103714Written as denufosol tetrasodium (INS37217)
- A Pharmacokinetic Evaluation Study in Healthy VolunteersCompletedPhase 1Merck Sharp & Dohme LLCNCT00210093Written as denufosol tetrasodium (INS37217)
- A Pharmacokinetic Evaluation Study in Healthy VolunteersCompletedPhase 1Merck Sharp & Dohme LLCNCT00210054Written as denufosol tetrasodium (INS37217)
- A Study in Subjects With Retinal DetachmentCompletedPhase 1Merck Sharp & Dohme LLCNCT00210067Written as denufosol tetrasodium (INS37217) Intravitreal Injection
- Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal DetachmentTerminatedPhase 2Merck Sharp & Dohme LLCNCT00083967Written as denufosol tetrasodium (INS37217) Intravitreal Injection
- Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung DiseaseTerminatedPhase 2Merck Sharp & Dohme LLCNCT00425165Written as denufosol tetrasodium (INS37217) Inhalation Solution
- A Study in Adult and Pediatric Patients With Cystic FibrosisCompletedPhase 1/2Merck Sharp & Dohme LLCNCT00034515Written as denufosol tetrasodium (INS37217) Inhalation Solution
- Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung DiseaseCompletedPhase 2Merck Sharp & Dohme LLCNCT00056147Written as denufosol tetrasodium (INS37217)
- A Study in Pediatric Patients With Cystic Fibrosis Lung DiseaseCompletedPhase 2Merck Sharp & Dohme LLCNCT00130182Written as denufosol tetrasodium (INS37217)
- A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular EdemaWithdrawnPhase 2Merck Sharp & Dohme LLCNCT00135655Written as denufosol tetrasodium (INS37217) Intravitreal Injection
Codes
What other systems call denufosol tetrasodium · ClinicalTrials.gg INT004477
- MeSH (NLM) C465279denufosol tetrasodiumConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 82M942WZ4ADENUFOSOL TETRASODIUMConfirmed FDA, NLM, Wikidata
- Wikidata Q27269345denufosol tetrasodiumConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C171672Denufosol TetrasodiumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C465279 | denufosol tetrasodium | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 82M942WZ4A | DENUFOSOL TETRASODIUM | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27269345 | denufosol tetrasodium | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C171672 | Denufosol Tetrasodium | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.